Infiniti Medical is a global company that designs and distributes medical devices for the veterinary market. With a presence in over 30 countries, we are the largest provider of minimally invasive devices for the veterinary market.
The company’s core business is designing and distributing devices that target diseases in the companion animal market. We focus on devices commonly used in interventional cardiology, interventional radiology, minimally invasive surgery, and endoscopic procedures.
Management & Advisors
Thomas J. Fogarty, MD
Dr. Thomas J. Fogarty is an internationally recognized cardiovascular surgeon, inventor, entrepreneur, and investor. He has been involved with a wide spectrum of innovations in business and technology, serving as founder/co-founder, and Chairman/board member of over 30 medical device companies, the majority based on devices designed and developed by Fogarty Engineering, Inc. Dr. Fogarty has published approximately 180 scientific articles and textbook chapters in fields of general and cardiovascular surgery, and is the author or co-author of more than 125 patents and patent applications.
His patents include the “industry standard” Fogarty balloon embolectomy catheter (now owned by Edwards Lifesciences), and the widely used Aneurx Stent Graft (now owned by Medtronic). Dr. Fogarty is the recipient of countless awards and honors; most significantly, he is the recipient of the Jacobson Innovation Award of the American College of Surgeons, the 2000 Lemelson-MIT prize for Invention and Innovation and was inducted into the Inventors Hall of Fame in December 2001 and The National Academy of engineering. Dr. Fogarty is currently Adjunct Clinical Professor of Surgery at Stanford University.
Previously, he has held positions as President, Medical Staff at Stanford University Medical Center, and Director, Cardiovascular Surgery at Sequoia Medical Center. Dr. Fogarty was born in Cincinnati, Ohio and received his undergraduate education at Xavier University and his medical degree from the University of Cincinnati. He completed his residency at the University of Oregon. Dr. Fogarty was a founder and general partner of Three Arch Partners and Emergent Medical Partners.
Jeffrey Solomon, MD, MBA
Jeffrey earned undergraduate degrees with honors from Brown University in Biology and Classics. He graduated from the University of Pennsylvania School of Medicine and was elected to the AOA honor society. He then completed a residency in diagnostic radiology and a fellowship in interventional radiology at the Hospital of the University of Pennsylvania.
As part of his post-graduate training he earned an MBA from the Wharton School of Business with a concentration in health care management. After graduation Jeffrey stayed on as faculty at the University of Pennsylvania School of Medicine and developed a clinical practice in interventional radiology at the Hospital of the University of Pennsylvania.
During his tenure he helped pioneer the field of veterinary interventional radiology by drawing on his experience treating human patients. He was appointed faculty to the University of Pennsylvania School of Veterinary Medicine and has lectured world wide on the topics of human and veterinary interventional radiology. He has co-authored numerous papers in both the human and veterinary literature and is the co-author of Radiology Secrets, a book that has been translated into 5 languages. His primary area of interest is innovation in the field of medical devices.
He holds a faculty position at the Wharton School of business and teaches a class on the medical device industry.
Jared Finegold, MBA
Jared graduated with honors from the Wharton School of the University of Pennsylvania, receiving both BSE and MBA degrees in finance and management. Prior to Infiniti Medical, Jared was an Associate in the Mergers & Acquisitions group at Rothschild in New York.
In addition, Jared worked at the Credit Suisse First Boston Technology Group in Palo Alto, covering both software and semiconductor companies within CSFB’s investment banking division.
Chick Weisse, VMD, DACVS
Chick completed his small animal surgical residency training at the Veterinary Hospital of the University of Pennsylvania in 2002 and then pursued advanced training through a customized fellowship in Interventional Radiology at the (human) Hospital of the University of Pennsylvania in 2003. He held dual appointments in surgery and radiology as an Assistant Professor at both the veterinary and human hospitals, respectively (Univ. of Pennsylvania) before coming to the Animal Medical Center in New York City in 2009 as staff surgeon and Director of Interventional Radiology Services.
Educational interests include expanding minimally-invasive veterinary interventional radiology (IR) techniques through describing new procedures and training veterinarians. Research interests include IR techniques for non-resectable and metastatic cancers, palliative stenting for malignant obstructions, vascular anomalies such as portosystemic shunts and AVMs, and stenting for tracheal collapse.
J. Casey McGlynn, JD
J. Casey McGlynn joined Wilson Sonsini Goodrich & Rosati in 1978 and formed the Life Sciences Group at the firm in 1990. It is a nationally recognized leader in the representation of startup and emerging growth companies in the life sciences field. Mr. McGlynn has one of the largest practices in the country focused on Medical Devices.
Mr. McGlynn has formed, sold and taken public many of the most important medical device companies started during the last 25 years. These companies include Anatros Corporation (predecessor to Tyco’s IV business), Advanced Cardiovascular Systems and Devices for Vascular Interventions (predecessors to Guidant’s vascular business, now Abbott Vascular), Aneurx (predecessor to Medtronic’s aortic aneurism business), Arthrocare (ARTC), Biopsys Medical (predecessor to JNJ’s women’s health business), Cardiac Pathways (now part of BSX’s EP catheter business), Cardiothoracic Systems (predecessor to Guidant’s cardiac surgery business), Conor MedSystems (now part of Cordis/JNJ), Cutera (CUTR), CVIS (predecessor to BSX’s vascular ultrasound business), Eyeonics (part of Bausch & Lomb’s refractive surgery division), FoxHollow Technologies (now part of eV3), Fusion Medical (predecessor to Baxter’s surgical sealant business), HeartStream (predecessor to Phillips’ external defibrillator business), Kyphon (predecessor to Medtronic’s Kyphoplasty business), Perclose (predecessor to Abbott’s vascular closure business), Somnus Medical (predecessor to Gyrus’ ENT business), Spinal Concepts (predecessor to Abbott’s orthopedics business), Ventana Medical Systems (part of Roche’s immunohistochemistry business), and Ventritex (predecessor to St Jude’s CRM business).